×
Evoke Pharma Total Liabilities 2012-2024 | EVOK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Evoke Pharma total liabilities from 2012 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Evoke Pharma Total Liabilities 2012-2024 | EVOK
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Evoke Pharma total liabilities from 2012 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Teva Pharmaceutical Industries (TEVA)
$19.4B
Dr Reddy's Laboratories (RDY)
$12.6B
BridgeBio Pharma (BBIO)
$5.1B
Bausch Health Cos (BHC)
$3.4B
Amphastar Pharmaceuticals (AMPH)
$2.4B
Supernus Pharmaceuticals (SUPN)
$2B
Taysha Gene Therapies (TSHA)
$307M
Personalis (PSNL)
$241M
Assembly Biosciences (ASMB)
$106M
Sol-Gel Technologies (SLGL)
$16M
Teligent (TLGT)
$0M